Switch theme
Sign up to access all valuation multiples
Maternus-Kliniken AG operates as a German healthcare company focused on senior housing, care facilities, and rehabilitation clinics.
1996
1.9K+
LTM Revenue n/a
LTM EBITDA n/a
$199M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Maternus-Kliniken has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Maternus-Kliniken achieved revenue of $110M and an EBITDA of $5.1M.
Maternus-Kliniken expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Maternus-Kliniken valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $110M | n/a | XXX | XXX | XXX |
| Gross Profit | $105M | $93.4M | XXX | XXX | XXX |
| Gross Margin | 95% | NaN% | XXX | XXX | XXX |
| EBITDA | $5.1M | n/a | XXX | XXX | XXX |
| EBITDA Margin | 5% | NaN% | XXX | XXX | XXX |
| Net Profit | -$2.7M | -$15.1M | XXX | XXX | XXX |
| Net Margin | -2% | NaN% | XXX | XXX | XXX |
| Net Debt | $94.1M | $113M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Maternus-Kliniken's stock price is EUR 1 (or $1).
Maternus-Kliniken has current market cap of EUR 28.1M (or $30.2M), and EV of EUR 185M (or $199M).
See Maternus-Kliniken trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $199M | $30.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Maternus-Kliniken has market cap of $30.2M and EV of $199M.
Maternus-Kliniken's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Maternus-Kliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Maternus-Kliniken and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $199M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMaternus-Kliniken's NTM/LTM revenue growth is n/a
Maternus-Kliniken's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Maternus-Kliniken's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Maternus-Kliniken's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Maternus-Kliniken and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 95% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Maternus-Kliniken acquired XXX companies to date.
Last acquisition by Maternus-Kliniken was XXXXXXXX, XXXXX XXXXX XXXXXX . Maternus-Kliniken acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Maternus-Kliniken founded? | Maternus-Kliniken was founded in 1996. |
| Where is Maternus-Kliniken headquartered? | Maternus-Kliniken is headquartered in Germany. |
| How many employees does Maternus-Kliniken have? | As of today, Maternus-Kliniken has 1.9K+ employees. |
| Is Maternus-Kliniken publicy listed? | Yes, Maternus-Kliniken is a public company listed on ETR. |
| What is the stock symbol of Maternus-Kliniken? | Maternus-Kliniken trades under MAK ticker. |
| When did Maternus-Kliniken go public? | Maternus-Kliniken went public in 1997. |
| Who are competitors of Maternus-Kliniken? | Similar companies to Maternus-Kliniken include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Maternus-Kliniken? | Maternus-Kliniken's current market cap is $30.2M |
| Is Maternus-Kliniken profitable? | Yes, Maternus-Kliniken is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
